EP Patent

EP2178500A2 — Dry-powder medicament

Assigned to Norton Healthcare Ltd · Expires 2010-04-28 · 16y expired

What this patent protects

This invention relates to a dry powder medicament and particularly to a medicament which provides improved fine particle fraction. The method for preparing the inhalable dry-powder medicament comprises the steps of: (i) fractionating a particulate active ingredient based on aerod…

USPTO Abstract

This invention relates to a dry powder medicament and particularly to a medicament which provides improved fine particle fraction. The method for preparing the inhalable dry-powder medicament comprises the steps of: (i) fractionating a particulate active ingredient based on aerodynamic particle size, (ii) recovering at least one fraction of the particulate active ingredient and (iii) combining the recovered fraction with a carrier to provide the inhalable dry-powder medicament. A dry-powder medicament per se is also described.

Drugs covered by this patent

Patent Metadata

Patent number
EP2178500A2
Jurisdiction
EP
Classification
—
Expires
2010-04-28
Drug substance claim
No
Drug product claim
No
Assignee
Norton Healthcare Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.